Guardian Pharmacy Services, INC Form 4 insider transactions

Fred Burke, CEO of Guardian Pharmacy Services, converted 1.3 million Class B shares into Class A common stock as part of a pre-scheduled plan.

Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the sale of 415,049 shares of Class A Common Stock for approximately $8.37 million through pre-arranged transactions.

William E. Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported the sale of over 4 million shares of Class A Common Stock for approximately $20.16 per share across two transactions.

A director and 10% owner of Guardian Pharmacy Services, Inc., Thomas J. Salentine Jr., through Bindley Capital Partners I, LLC, sold over 4.1 million shares of Class A Common Stock for approximately $84 million.

John Ackerman, a Director and 10% owner of Guardian Pharmacy Services, Inc., sold a total of 1,284,579 shares of Class A Common Stock for $20.16 per share through an underwriting agreement.

Fred Burke, President and CEO of Guardian Pharmacy Services, Inc., has reported the sale of 885,807 shares of Class A Common Stock for approximately $17.85 million, as part of a pre-arranged underwriting agreement.

David K. Morris, Executive Vice President and Chief Financial Officer of Guardian Pharmacy Services, Inc., sold 437,759 shares of Class A Common Stock for approximately $8.8 million through pre-arranged Rule 10b5-1 plans.

Bindley Capital Partners I, LLC, a 10% owner and director of Guardian Pharmacy Services, Inc., has sold over 4.1 million shares of Class A Common Stock for approximately $83.88 million.

Director Steven D. Cosler reports acquisition of Guardian Pharmacy Services Class A Common Stock.

Mary Sue Patchett, a director at Guardian Pharmacy Services, acquired 3,901 shares of Class A Common Stock through restricted stock units on May 9, 2025.

Director Randall J Lewis reports acquisition of Guardian Pharmacy Services Class A Common Stock.

Thomas J. Salentine Jr., a director at Guardian Pharmacy Services, converted a portion of his Class B common stock into Class A common stock on March 28, 2025.

Director Fred Burke converts 1,298,826 shares of Class B common stock to Class A common stock in Guardian Pharmacy Services, Inc.

William E. Bindley, a director and 10% owner of Guardian Pharmacy Services, converted 6,100,176 shares of Class B common stock into Class A common stock on March 28, 2025.

David K. Morris, an executive at Guardian Pharmacy Services, converted 641,869 shares of Class B common stock into Class A common stock on March 28, 2025, according to a recent SEC filing.

John Ackerman, a director of Guardian Pharmacy Services, reported the conversion of Class B common stock into Class A common stock, as per the company's Amended and Restated Certificate of Incorporation.

Kendall Forbes, an executive at Guardian Pharmacy Services, converted 608,570 shares of Class B common stock into Class A common stock on March 28, 2025, according to a Form 4 filing.

Kendall Forbes, an Executive Vice President at Guardian Pharmacy Services, acquired 10,385 restricted stock units on February 5, 2025, which will vest into Class A common stock on February 5, 2028.

David K. Morris, an executive at Guardian Pharmacy Services, was granted 10,385 restricted stock units that will vest in full on February 5, 2028.

Director Steven D. Cosler purchased 7,000 shares of Guardian Pharmacy Services Class A Common Stock at a weighted average price of $21.22.

Director William E. Bindley reports acquiring 24,400,702 shares of Class B Common Stock in Guardian Pharmacy Services due to a merger agreement.

David K. Morris, Executive Vice President and CFO of Guardian Pharmacy Services, reports acquiring 2,567,477 shares of Class B Common Stock following a merger agreement.

Fred Burke, a director and officer of Guardian Pharmacy Services, reports acquiring 5,195,303 shares of Class B common stock as a result of a merger agreement.

Director John Ackerman reports acquisition of Class B Common Stock in Guardian Pharmacy Services following a merger, convertible to Class A Common Stock over time.

Thomas J. Salentine Jr., a director of Guardian Pharmacy Services, acquired shares of Class A and Class B common stock through a directed share program and a merger agreement.

Mary Sue Patchett, a director at Guardian Pharmacy Services, acquired shares of Class A Common Stock through a directed share purchase program and received restricted stock units in connection with the company's initial public offering.

Kendall Forbes, an executive at Guardian Pharmacy Services, acquired shares of Class B Common Stock as part of a merger agreement.

Director Randall J Lewis reports acquisition of Class A Common Stock through a directed share purchase and receipt of restricted stock units in Guardian Pharmacy Services, Inc.

Director Steven D. Cosler purchased shares and received restricted stock units in Guardian Pharmacy Services' initial public offering.